Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

PharmaCann

Explore full profile

largest vertically-integrated and unified medical cannabis company

Oak Park, United StatesFounded 2014Biotech & Life Sciences
Valuation <$5M Last recorded · 2026
Headcount 500–1k Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for PharmaCann and the history behind them.

About PharmaCann

PharmaCann is a prominent player in the cannabis industry, dedicated to improving people's lives through the cultivation, production, and distribution of high-quality cannabis products. Founded in 2014, PharmaCann has quickly grown to become one of the largest vertically integrated cannabis companies in the United States. This means they control every step of the process—from growing the cannabis plants to processing them into various products and finally selling them in their own dispensaries. This vertical integration allows PharmaCann to maintain high standards of quality and safety across all their products.

The company operates in a rapidly expanding market, focusing on both medical and adult-use cannabis. They are licensed to operate in eight states, including Illinois, Maryland, Massachusetts, New York, Ohio, and Pennsylvania. Their product offerings include a range of cannabis-related items such as flower, edibles, tinctures, and topicals, all designed to meet the diverse needs of their clients.

PharmaCann serves a broad spectrum of clients, from medical patients seeking relief from various conditions to adult consumers looking for wellness and recreational products. The company’s mission is to provide safe, reliable, and top-quality cannabis products that are both effective and affordable. By investing in their employees, state-of-the-art facilities, and rigorous research and development, PharmaCann aims to lead the industry in innovation and quality.

The business model of PharmaCann revolves around vertical integration, which helps them control costs and ensure product quality. They make money by selling their products directly to consumers through their network of dispensaries, as well as through wholesale channels to other retailers. Their commitment to truth and transparency, along with their focus on sustainable practices, positions them as a trusted name in the cannabis industry.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2014
Headquarters
Oak Park, United States
Employees
671
Open positions
41
Dealroom signal
74.2/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotech & Life Sciences, Biotechnology, Cannabis, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
b2b

Funding history

8 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
DEBTDebt Apr 2024 $74M — Undisclosed ↗
GROWTH EQUITY VCOther financing Apr 2024 $18M — Undisclosed ↗
Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Growth signals

PharmaCann website traffic

Latest recorded traffic for PharmaCann is 11K monthly website visits, up 17% over the last three months. PharmaCann's team grew 38.1% over the past year.

Latest monthly visits11K 3-month web change+17% 1-year team growth+38.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Other known investors1 additional known investor

  • MedMen
Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States98.7%
🇵🇪 Peru0.5%
🇦🇺 Australia0.3%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about PharmaCann on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See PharmaCann’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.